CM discussed at WHO assembly

May 21, 2025
Valuable testimony
Valuable testimony:

At a panel discussion, Secretary for Health Prof Lo Chung-mau (centre) speaks about Hong Kong’s experiences in promoting high-quality and high-standard Chinese medicine development

Secretary for Health Prof Lo Chung-mau spoke at a panel discussion session and met World Health Organization (WHO) officials yesterday as he continued his attendance at the WHO’s 78th World Health Assembly in Geneva, Switzerland.

 

In the morning, Prof Lo and Director of Health Dr Ronald Lam listened to remarks made by State Council Vice Premier Liu Guozhong at the assembly’s “High Level Segment”.

 

Prof Lo commented: “The Hong Kong Special Administrative Region Government spares no efforts to complement the nation’s strategies to contribute to the building of a global community of health for all.”

 

Prof Lo and Dr Lam also attended a side event themed “Improving Universal Health Coverage through the implementation of WHO Traditional Medicine Strategy 2025-2034”, which was hosted by the National Administration of Traditional Chinese Medicine along with the health authorities of Malaysia, Nepal, Saudi Arabia and Seychelles.

 

In a panel discussion, Prof Lo spoke about Hong Kong’s experiences in promoting high-quality and high-standard Chinese medicine (CM) development.

 

He said: “The Hong Kong SAR Government will leverage Hong Kong’s strengths in its healthcare system, regulatory framework, standard-setting, clinical research, trade, and more to develop the city into a bridgehead for the internationalisation of CM.”

 

In terms of CM practice, he explained that the Hospital Authority has accumulated extensive experience through its integrated Chinese-Western medicine services over the years. The Chinese Medicine Hospital of Hong Kong is developing a “Hong Kong model” that includes pure CM, CM-predominant, and integrated Chinese-Western medicine clinical services, with a view to promoting CM at an international level.

 

With regard to CM drugs, Prof Lo said Hong Kong’s Government Chinese Medicines Testing Institute is actively advancing scientific research, education and international exchanges on CM drug testing. This includes developing internationally recognised reference standards and testing methods for CM drugs, and promoting the commercial application of such methods, with a view to developing Hong Kong into an international hub for CM testing and quality control.

 

Prof Lo and Dr Lam also met the WHO’s Director of Nutrition & Food Safety Luz María De Regil to discuss strategies and interventions for obesity and weight management. Prof Lo said that the Hong Kong SAR Government will strive to halt the rise of obesity by implementing life-course interventions.

 

The delegation will arrive back in Hong Kong tomorrow.

Back to top